Sun Pharma shares: Jefferies sees healthy upside after recent acquisition1 min read 31 Mar 2023, 09:58 AM IST
Sun Pharma recently completed the acquisition of US-based Concert Pharmaceuticals
Sharing its takeaways from the call with Jefferies US analyst on Concert Pharma Acquisition until its recent acquisition by Sun Pharma, Jefferies in a note said that the analyst Dr Maurice Raycroft Ph.D Maury provided insights on the positioning of Concert's lead drug Deuruxolitinib for treatment of alopecia areata.
Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!Let’s get started
Select your Category